Executive Director, Clinical Science, Cardiometabolic

Prioritize, resource align, and support key development milestones across a portfolio of cardiometabolic programs spanning cardiovascular, respiratory, metabolism, and atherosclerosis. Provide strategic oversight for assets in multiple development stages while partnering with therapeutic area leaders and cross-functional partners to drive execution and delivery of milestones. Ensure Clinical Science contributions support regulatory submissions, health authority interactions, and lifecycle management by applying expertise to inform strategy across evolving science and regulatory considerations. Optimize allocation of Clinical Science resources and budgets to align with business priorities, serving as a senior escalation point for scientific and resource-related issues. Establish and sustain high standards for scientific rigor, study oversight, and regulatory readiness while championing the adoption of AI, advanced analytics, and digital capabilities to enhance productivity and decision-making. Lead a high-performing Clinical Science organization through talent planning, succession management, and the development of future leaders, fostering a culture of inclusion, accountability, and continuous improvement. Represent Clinical Science in governance forums and shape enterprise priorities through cross-functional influence.